Market revenue in 2023 | USD 14,627.3 million |
Market revenue in 2030 | USD 39,152.2 million |
Growth rate | 15.1% (CAGR from 2023 to 2030) |
Largest segment | Reagents |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents, Kits, Instruments, Enzymes, Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epigenetics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 33.45% in 2023. Horizon Databook has segmented the Global epigenetics market based on reagents, kits, instruments, enzymes, services covering the revenue growth of each sub-segment from 2018 to 2030.
The global Epigenetics market is expected to increase as a result of the increasing number of epigenetic applications in the treatment various life-threatening disorders including cancer and other illnesses. Because epigenetics has been shown to be highly effective in treating specific types of cancer, many research institutes are deeply investigating it with the aim of producing essential vaccines and drugs for abnormalities that have yet to receive any effective therapies assigned to them. For instance, in 2022, according to American Cancer Society, it was estimated that, Several organizations, including the National Cancer Institute, Human Epigenome Consortium, and National Institutes of Health, have pushed for more funding in epigenetics, both for research and for commercialization, which is expected to support worldwide expansion in the coming years.
Horizon Databook provides a detailed overview of global-level data and insights on the Global epigenetics market , including forecasts for subscribers. This global databook contains high-level insights into Global epigenetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Product | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 2,867.9 | 3,213.9 | 3,667.9 | 4,290.4 | 4,919.5 | 5,586.2 | 6,340.4 | 7,211.1 | 8,220.0 | 9,400.4 | 10,779.6 | 12,415.3 | 14,360.9 | 14.4% |
Europe | 2,330.4 | 2,632.6 | 3,028.9 | 3,572.1 | 4,129.9 | 4,728.9 | 5,413.0 | 6,209.1 | 7,139.1 | 8,235.6 | 9,527.5 | 11,071.2 | 12,921.7 | 15.4% |
Asia Pacific | 1,576.6 | 1,796.7 | 2,085.5 | 2,481.6 | 2,895.1 | 3,345.4 | 3,864.7 | 4,474.5 | 5,193.3 | 6,048.2 | 7,064.3 | 8,288.9 | 9,769.5 | 16.5% |
Latin America | 321.2 | 355.1 | 399.8 | 461.2 | 521.5 | 583.9 | 653.4 | 732.5 | 822.9 | 927.4 | 1,047.7 | 1,188.8 | 1,354.4 | 12.8% |
MEA | 236.9 | 255.9 | 281.5 | 317.2 | 350.3 | 383.0 | 418.3 | 457.6 | 501.6 | 551.3 | 607.3 | 671.8 | 745.8 | 10.0% |
Overall | 7,333.0 | 8,254.3 | 9,463.5 | 11,122.4 | 12,816.4 | 14,627.3 | 16,689.8 | 19,084.7 | 21,876.9 | 25,162.8 | 29,026.5 | 33,635.9 | 39,152.2 | 15.1% |
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account